10-hydroxycamptothecin has been researched along with 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Pan, X; Qin, LZ; Wu, CB; Wu, LN; Zhang, J; Zhang, X | 1 |
| Gu, Y; Huang, Y; Li, G; Mei, L; Pan, X; Qin, L; Shan, Z; Wu, C | 1 |
2 other study(ies) available for 10-hydroxycamptothecin and 3,7,11,15-tetramethyl-1,2,3-hexadecanetriol
| Article | Year |
|---|---|
[Preparation and in vitro embolic efficiency evaluation of hydroxycamptothecine-loaded liquid embolic agent].
Topics: Antineoplastic Agents, Phytogenic; Calorimetry, Differential Scanning; Camptothecin; Delayed-Action Preparations; Fatty Alcohols; Liquid Crystals; Scattering, Small Angle; Water; X-Ray Diffraction | 2014 |
Phytantriol based liquid crystal provide sustained release of anticancer drug as a novel embolic agent.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Drug Liberation; Embolization, Therapeutic; Fatty Alcohols; Hep G2 Cells; Humans; Liquid Crystals; Mice; NIH 3T3 Cells; Solvents; Time Factors | 2016 |